Hide Board Information

Show Board Information

CNS Pharmaceuticals Inc. CNSP

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/18/2024 4:15:33 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 62

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Stock Message Board

1. CNSP Company Profile

    

2. CNSP Time & Sales

    

3. CNSP Recent News

    

4. CNSP Filings

    

5. CNSP Financials

    

6. CNSP Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

136	NetworkNewsBreaks CNS Pharmaceuticals	NetworkNewsWire	10/07/2022 5:53:40 PM
135	New Laws on Abortion May Complicate Cancer	NetworkNewsWire	10/06/2022 5:24:11 PM
134	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	10/03/2022 4:51:48 PM
133	UC San Diego Offers New Radiation Therapy That	NetworkNewsWire	09/30/2022 4:31:13 PM
132	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	09/28/2022 3:52:18 PM
131	Study Finds That Endometriosis Prognosis Worsens	NetworkNewsWire	09/23/2022 6:43:34 PM
130	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	09/23/2022 6:16:14 PM
129	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)	NetworkNewsWire	09/19/2022 4:21:37 PM
128	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	09/16/2022 3:54:35 PM
127	Focused Ultrasound May Offer Easier Way to Treat	NetworkNewsWire	09/15/2022 5:24:01 PM
126	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Takes	NetworkNewsWire	09/13/2022 4:17:09 PM
125	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Efforts	NetworkNewsWire	09/09/2022 4:13:00 PM
124	Accessibility Issues Prevent Individuals in Rural	NetworkNewsWire	09/07/2022 4:49:48 PM
123	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Posts	NetworkNewsWire	09/07/2022 4:26:13 PM
122	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	09/07/2022 4:10:48 PM
121	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), Moving	NetworkNewsWire	09/01/2022 4:25:12 PM
120	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Looking	NetworkNewsWire	08/30/2022 5:16:14 PM
119	Study Looks into Why Deadly Brain Tumors Continue	NetworkNewsWire	08/29/2022 5:25:00 PM
118	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	08/23/2022 4:52:03 PM
117	Targeted Cancer Vaccines Show Promise in Halting	NetworkNewsWire	08/19/2022 5:19:53 PM
116	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	08/15/2022 4:18:16 PM
115	Researchers Want to Manage Cancer By Keeping	NetworkNewsWire	08/12/2022 5:00:31 PM
114	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	08/12/2022 4:43:51 PM
113	Study Finds That Ketogenic Diet May Help Patients	NetworkNewsWire	08/04/2022 6:13:27 PM
112	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Advances	NetworkNewsWire	08/04/2022 6:06:43 PM
111	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)	NetworkNewsWire	08/02/2022 5:01:29 PM
110	Researchers Develop Blood Test to Improve Tumor	NetworkNewsWire	07/27/2022 5:15:34 PM
109	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	07/25/2022 4:35:32 PM
108	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	07/20/2022 4:37:03 PM
107	Preclinical Study Uncovers Potential Key to	NetworkNewsWire	07/18/2022 5:01:19 PM
106	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Expands	NetworkNewsWire	07/11/2022 4:42:53 PM
105	Study Suggests That Test of Memory May Signal	NetworkNewsWire	07/07/2022 5:29:16 PM
104	AI May Help Improve Brain Cancer Diagnosis	NetworkNewsWire	06/29/2022 5:15:51 PM
103	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	06/23/2022 6:46:45 PM
102	Study Suggests Healthcare Workers Dont Know	NetworkNewsWire	06/22/2022 5:00:54 PM
101	Symptoms of Brain Tumors To Watch For Data shows	NetworkNewsWire	06/15/2022 4:42:13 PM
100	Study Finds That Brain Tumors May Originate from	NetworkNewsWire	06/08/2022 5:29:05 PM
99	Exposure to Wildfires Amplifies Cancer Risk, New	NetworkNewsWire	06/01/2022 4:51:30 PM
98	Genomic Sequencing Offers Hope in Diagnosis,	NetworkNewsWire	05/24/2022 4:53:04 PM
97	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	05/24/2022 4:01:21 PM
96	NetworkNewsBreaks CNS Pharmaceuticals	NetworkNewsWire	05/23/2022 3:48:08 PM
95	Lantern Pharma to Host Glioblastoma Multiforme	NetworkNewsWire	05/19/2022 4:40:22 PM
94	NetworkNewsBreaks CNS Pharmaceuticals	NetworkNewsWire	05/18/2022 4:04:51 PM
93	Updated Guidelines Shed Light on Using Radiation	NetworkNewsWire	05/16/2022 4:55:58 PM
92	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	05/16/2022 3:47:25 PM
91	Researchers Develop Models to Better Understand	NetworkNewsWire	05/11/2022 5:06:34 PM
90	Investor Event Turns Spotlight on Novel Brain	NetworkNewsWire	05/11/2022 4:24:50 PM
89	Study Finds Strong Link Between Hormone Drug,	NetworkNewsWire	05/06/2022 5:54:10 PM
88	NetworkNewsBreaks CNS Pharmaceuticals	NetworkNewsWire	05/05/2022 4:03:45 PM
87	Johns Hopkins Researchers Receive Millions for	NetworkNewsWire	05/03/2022 5:08:22 PM

Newer

Older

Recent Articles

• Australia's Bold Move to Safeguard Children's Privacy Online
• Pathway to Growth: Palantir's Ambitious AI Future and Price Target
• Challenges Faced by Chinese Startups Amidst Investment Landscape
• Explore the Growth of Bluesky Amid Social Media Changes
• Elon Musk Amused by Bitcoin's Dip After Analyst's Praise
• Mynaric AG Faces Class Action Lawsuit: What Investors Should Know
• Iris Energy Investors Urged to Join Class Action Lawsuit
• Terran Orbital Faces Class Action Lawsuit: What Investors Should Know
• Franklin Resources Faces Investigation: What Investors Should Know
• Class Action Lawsuit Filed Against Xiao-I Corporation: Key Insights
• Quanterix Under Investigation for Financial Mismanagement Concerns
• Evolv Technologies Faces Class Action Lawsuit Amid Financial Concerns
• Marqeta Faces Legal Scrutiny Amid Revenue Forecast Cuts
• Investigation into The Estée Lauder Companies, Inc. Begins
• Class Action Lawsuit Impacting iLearningEngines Investors
• Flux Power's Legal Challenges: What Investors Should Know
• Class Action Lawsuit Filed Against Acadia Healthcare: Key Insights
• Explore Apple’s Exciting Black Friday Gift Card Promotions
• ONEOK Expands Reach with $4.3 Billion EnLink Acquisition
• Investors on Alert: Class Action Lawsuit Filed Against WM Technology
• Adani Group Faces Bond Market Turmoil Amid Fraud Claims
• Impact of New Tax Policies on British Business Investment Trends
• Strong Demand for Electric Vehicles Anticipated Until 2024
• Bitcoin's Resilience Amid Market Fluctuations This Thanksgiving
• SG Fleet Group Surges Amid $785 Million Buyout Talks
• Intel Adjusts to Reduced CHIPS Act Funding Amid Challenges
• U.S. Government Adjusts Intel's Chips Grant to Below $8 Billion
• Oil Prices Stabilize: Middle East Tensions and Ceasefire Talks
• Geopolitical Tensions Propel Oil Prices: A Two-Week Overview
• Cassava Sciences Announces Important Corporate Conference Call
• Confidence Boost in BioPharma: Impact of Makary's Nomination
• Air New Zealand Anticipates Lower Earnings Amid Engine Woes
• Wedbush Boosts Ratings for Snowflake and Elastic Amid AI Surge
• Market Reaction to Scott Bessent's U.S. Treasury Role
• Investors Encouraged to Act on Humacyte Class Action Lawsuit
• Australian Regulator Keeps Home Loan Rules Amid Job Market Concerns
• Dollar's Shift: Analyzing Market Reactions After Bessent's Pick
• U.S. Stock Futures Surge with Trump’s Treasury Nominee Scott Bessent
• Class Action Lawsuit Announced Against Acadia Healthcare Company
• McDonald's Invests $100 Million to Restore Customer Trust
• Bumble Inc. Investors: Important Class Action Deadline Approaches
• Investors Urged to Act by November 29 Deadline in Class Action
• Global Efforts Intensify for a Comprehensive Plastics Treaty
• NOVONIX Secures Major Offtake Agreement with PowerCo for Graphite Supply
• Emerging Markets Face Challenges Amid US Economic Dominance
• Investigation into Quanterix Corporation Securities Claims
• Paragon 28, Inc. Investors Invited to Join Class Action Against Company
• Sunlight Financial Holdings Faces Class Action Lawsuit Risks
• Bumble Inc. Faces Class Action: Key Insights for Investors
• Investors Urged to Join ASML Class Action for Recovery